Want to join the conversation?
Banking firm $GS reported 1Q16 OpEx of $4.76Bil, down 29% versus 1Q15. The accrual for compensation and benefits expenses on condensed consolidated statements of earnings fell 40% versus 1Q15, reflecting a fall in net revenue. Ratio of compensation and benefits to net revenue in 1Q16 was flat versus 1Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?